(Q84557567)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20621094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20621094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

7

Carsten Bokemeyer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20621094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Caroline Pabst

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20621094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Jozef Zustin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20621094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Frank Jacobsen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20621094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Tim Luetkens

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20621094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Nicolaus Kröger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20621094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Georgia Schilling

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20621094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Guido Sauter

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20621094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Djordje Atanackovic

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20621094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Andreas Marx

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20621094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

14 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20621094%20AND%20SRC:MED&resulttype=core&format=json

Experimental and Molecular Pathology

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20621094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20621094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20621094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

175-181

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20621094%20AND%20SRC:MED&resulttype=core&format=json

Multiple myeloma: a review of the epidemiologic literature

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Advances in therapy of multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Cancer/testis genes in multiple myeloma: expression patterns and prognosis value determined by microarray analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

The epidemiology of multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

International staging system for multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Lenalidomide in combination with dexamethasone for the treatment of multiple myeloma after one prior therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Comparison of time trends in multiple myeloma incidence (1973-1997) in East Asia, Europe and United States, from Cancer Incidence in Five Continents, Vols IV-VIII

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Review of 1027 patients with newly diagnosed multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Cancer-testis antigens in haematological malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Prognostic value of cell proliferation (Ki-67 antigen) and nuclear DNA content in clinically resectable, distal bile duct carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Prognostic impact of cytogenetic aberrations in patients with multiple myeloma or monoclonal gammopathy of unknown significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

The Ki-67 protein: from the known and the unknown

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

Myeloma bone disease and treatment options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.06.011

10.1016/J.YEXMP.2010.06.011

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20621094%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference